article_metadata: Daniel C Julien Kara Woolgar Laura Pollard Holly Miller Ankit Desai Kristin Lindstrom Priya S Kishnani
article_metadata: 10.3389/fimmu.2020.01000
article_metadata: Front Immunol
article_metadata: 2020 May 21;11:1000.
article_metadata: mps ii enzyme replacement therapy hunter syndrome immune modulation neutralizing antibodies
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/32508845/
article_metadata: Enzyme Replacement Therapy / methods Iduronate Sulfatase / therapeutic use Immunoglobulins, Intravenous / therapeutic use Mucopolysaccharidosis II / therapy Rituximab / therapeutic use
article_metadata: Enzyme Replacement Therapy / methods Iduronate Sulfatase / therapeutic use Immunoglobulins, Intravenous / therapeutic use Mucopolysaccharidosis II / therapy Rituximab / therapeutic use Case Reports Antibodies, Neutralizing / metabolism Child, Preschool Female Humans Iduronate Sulfatase / genetics Iduronate Sulfatase / immunology Immune Tolerance Mucopolysaccharidosis II / immunology Sequence Deletion Antibodies, Neutralizing Immunoglobulins, Intravenous Rituximab Iduronate Sulfatase
article_metadata: PMC7253587
article_metadata: 32508845
article_metadata: Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome
article_metadata: 2020